Filter
2038
Filtered Results: 2038
Text search:
Neglected
Diseases
Featured
Recommendations
168
New Publications
418
Language
Document type
No document type
925
Studies & Reports
514
Guidelines
170
Strategic & Response Plan
97
Resource Platforms
92
Fact sheets
65
Manuals
62
Videos
34
Infographics
22
Training Material
18
Online Courses
14
Situation Updates
12
Brochures
6
Dashboards/Maps
5
App
2
Countries / Regions
Global
257
India
62
Africa
46
Latin America and the Carribbean
45
Uganda
38
Sierra Leone
37
Ethiopia
37
Liberia
34
Kenya
32
Bangladesh
28
Western and Central Europe
28
South Africa
27
Nepal
22
Rwanda
22
Malawi
22
Syria
20
Ghana
19
Zambia
19
Congo, Democratic Republic of
17
Tanzania
17
South Sudan
16
West and Central Africa
16
Asia
15
Nigeria
14
Mozambique
14
Brazil
14
South–East Asia Region
14
East and Southern Africa
13
Namibia
11
Colombia
11
Yemen
11
Middle East and North Africa
11
Eastern Europe
11
Guinea
10
Lesotho
9
Myanmar / Burma
9
Cameroon
8
Philippines
8
Indonesia
8
Sudan
8
Ukraine
8
Venezuela
8
Somalia
7
Germany
7
Botswana
7
Southern Africa
6
North America
6
Burkina Faso
5
Zimbabwe
5
Pakistan
4
Iraq
4
Jordan
4
Afghanistan
4
Egypt
4
Peru
4
Angola
4
Eastern Europe and Central Asia
4
Tajikistan
4
Senegal
3
Saudi Arabia
3
Haiti
3
China
3
Eswatini/ Swaziland
3
Bolivia
3
Paraguay
3
Albania
3
Russia
3
Lebanon
2
Turkey
2
Chad
2
Benin
2
Central African Republic
2
Argentina
2
El Salvador
2
Greece
2
Sri Lanka
2
Chile
2
Western Pacific Region
2
Djibouti
2
Laos
2
Iran
2
Vietnam
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Togo
1
Cambodia
1
Thailand
1
Mauritania
1
Ireland
1
Papua New Guinea
1
Dominican Republic
1
North Macedonia
1
Honduras
1
Ecuador
1
Libya
1
Madagascar
1
Mexico
1
Poland
1
Palestine
1
Italy
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Georgia
1
Uruguay
1
France
1
Mauritius
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
497
Clinical Guidelines
205
Public Health
140
Women & Child Health
83
Key Resources
68
Capacity Building
32
Pharmacy & Technologies
26
Annual Report MEDBOX
1
Toolboxes
NTDs
588
Mental Health
121
HIV
95
Planetary Health
82
Disability
74
TB
72
COVID-19
72
Global Health Education
63
Ebola
44
Conflict
36
Rapid Response
33
Caregiver
33
AMR
28
NCDs
28
Health Financing Toolbox
23
Refugee
22
Pharmacy
19
Natural Hazards
12
Social Ethics
12
Cholera
10
Zika
10
Polio
8
Specific Hazards
3
Health Financing
1
1 billion people are at risk of infection with leishmaniasis, a neglected disease strongly linked to poverty. There’s no single, simple cure: current treatments are complex and need to be adapted ...
Leishmaniasis is among the most neglected diseases. The most common form is cutaneous leishmaniasis that forms lesions on the skin.
The only treatment available for cutaneous leishmaniasis is high...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable t...
Website last accessed on 14.04.2023
Health workers Luke (Kenya), Juliana (Colombia), and Shishu (India) share the same hope for their patients with leishmaniasis: simple, oral treatments. For the first time ever, it seems leishmaniasis research is moving from neglect to a sense of hope.
The Leishmaniasis East Africa Platform (LEAP) was established to support the generation of scientific evidence for the development and distribution of new treatments for leishmaniasis in Eastern Africa.
Dieses Kurzdossier konzentriert sich besonders auf den Zusammenhang zwischen zwei übertragbaren
tropischen Armutserkrankungen – dem Wurmbefall des Darms durch Geohelminthen wie Spul-,
Peitschen- und Hakenwürmer sowie der Schistosomiasis (Bilharziose). Es zeigt Möglichkeiten zu
deren Bekämpf...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
More countries eliminate human African trypanosomiasis as a public health problem: Benin and Uganda (gambiense form) and Rwanda (rhodesiense form)
Human African trypanosomiasis (HAT), or sleeping sickness, transmitted by tsetse flies in sub-Saharan Africa, is a life-threatening ... that afflicts poor rural populations. It is caused by trypanosome parasites of 2 subspecies: Trypanosoma brucei gambiense in West and Central Africa, and T. b. rhodesiense in East Africa.
HAT transmission can be reduced and interrupted by deploying and maintaining capacities for testing people at risk in order to detect and treat cases, and by controlling tsetse populations that are in contact with humans.
The World Health Organization (WHO) endorses the use of population-based prevalence surveys for estimating the prevalence of trachoma. In general, the prevalence of TF in children aged 1–9 years and the prevalence of TT in adults aged ≥ 15 years are measured at the same time in any district bein...
As a high-burden neglected tropical disease, soil-transmitted helminth (STH) infections remain a major problem in the world, especially among children under five years of age. Since young children a...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. ...
Onchocerciasis, or river blindness, is a neglected tropical disease (NTD) caused by the parasitic worm Onchocerca volvulus. It is transmitted through repeated bites by blackflies of the genus Simuli...
Schistosomiasis, also known as bilharzia, is a disease caused by parasitic worms. Although the worms that cause schistosomiasis are not found in the United States, people are infected worldwide. In terms of impact this ... is second only to malaria as the most devastating parasitic disease. Schistosomiasis is considered one of the neglected tropical diseases (NTDs).
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No. 12, December 2019 2183
Buruli ulcer is a neglected tropical disease caused by My...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
GUIDE PRATIQUE À L’INTENTION DES PROGRAMMES DE LUTTE CONTRE LES MALADIES TROPICALES NÉGLIGÉES
This toolkit provides step-by-step guidance to NTD programme managers and partners on how to engage and work collaboratively with the WASH community to improve delivery of water, sanitation and hygien...
The Lancet olume 395, ISSUE 10232, P1259-1267, April 18, 2020. Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most ...
Current Tropical Medicine Reports (2018) 5:247–256 https://doi.org/10.1007/s40475-018-0166-2 .Purpose of the Review Buruli ulcer (BU) is a necrotizing and disabling cutaneous disease caused by Mycobacterium ulcerans, one of the skin-related ... tropical diseases (skin NTDs). This article aims to review the current knowledge of this disease and challenges ahead.
Cotonou declaration on buruli ulcer
recommended
Cotonou Declaration oBuruli Ulcer
Cotonou, Benin, 30 March 2009
Neglected tropical diseases kill, weaken or incapacitate millions of people every year, causing permanent physical suffering, social...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The ... is common in rural tropical communities in West and Central Africa, where access to proper health care is limited. Pathogenesis of the characteristic painless ulcers is linked to the elaboration by M. ulcerans of a lipid toxin called mycolactone that has potent cytopathic, immunosuppressive, and analgesic effects on a host of cells in cutaneous tissues. Mycolactone is known to profoundly inhibit secretion of a plethora of proteins that are essential for wound healing. Even though a combination antibacterial therapy of streptomycin and rifampicin for 8 weeks is effective for treatment, it relies on good and appropriate wound management to prevent secondary bacterial infections and improve healing. Evidence-based interventions for wound care in Buruli ulcer disease are often lacking and have relied on expert advice and recommendations. Surgical interventions are limited to debridement of necrotic tissue and grafting of extensive ulcers, usually after antibiotic therapy. Patients’ rehabilitation is an important component of care to reduce disabilities associated with the disease and proper integration into the community after treatment.
